CTOs on the Move

Maxant Technologies

www.maxant.com

 
Maxant Technologies, Inc is a Niles, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.maxant.com
  • 7540 N Caldwell Ave
    Niles, IL USA 60714
  • Phone: 847.588.2280

Executives

Name Title Contact Details

Similar Companies

Critical Homecare Solutions

Critical Homecare Solutions is a Conshohocken, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hermann Medical Supply

Hermann Medical Supply is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

av ox inc

av ox inc is a Van Nuys, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Immucor

For more than 30 years, Immucor has been a proud partner to thousands of hospitals, reference laboratories and donor centers. We remain focused on continuing to innovate as we work to advance the science of transfusion and transplantation diagnostics. We are guided by our corporate Mission and Values. We strive to create a world where anyone, anywhere in need of blood or an organ gets the right blood or organ that is safe, accessible and affordable. We will be guided by our Core Values of Respect, Integrity, Teamwork and Achievement. In doing so, we will: • strive to achieve the highest quality products and solutions; • bring forth and pursue innovations that advance patient safety; • honor our customers with the highest level of service.

JenaValve

JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.